CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features
about
Contrast Enhanced MRI in the Diagnosis of HCCMagnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acidNoninvasive Diagnosis of Hepatocellular Carcinoma: Elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guidelines Compared with Other Guidelines and Remaining IssuesSelection of patients with hepatocellular carcinoma for liver transplantation: Past and futureDifferentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents?Multimodal Imaging of Nanocomposite Microspheres for Transcatheter Intra-Arterial Drug Delivery to Liver Tumors.Recent Advances in the Imaging Diagnosis of Hepatocellular Carcinoma: Value of Gadoxetic Acid-Enhanced MRIClassifying CT/MR findings in patients with suspicion of hepatocellular carcinoma: Comparison of liver imaging reporting and data system and criteria-free Likert scale reporting models.Diagnostic accuracy of liver imaging reporting and data system (LI-RADS) v2014 for intrahepatic mass-forming cholangiocarcinomas in patients with chronic liver disease on gadoxetic acid-enhanced MRI.Liver imaging reporting and data system category 4 observations in MRI: Risk factors predicting upgrade to category 5.Diagnosis of Hepatocellular Carcinoma with Gadoxetic Acid-Enhanced MRI: 2016 Consensus Recommendations of the Korean Society of Abdominal Radiology.Major and ancillary magnetic resonance features of LI-RADS to assess HCC: an overview and update.MRI features of hepatocellular carcinoma related to biologic behaviorLiver Imaging Reporting and Data System on CT and gadoxetic acid-enhanced MRI with diffusion-weighted imaging.Corona Enhancement and Mosaic Architecture for Prognosis and Selection Between of Liver Resection Versus Transcatheter Arterial Chemoembolization in Single Hepatocellular Carcinomas >5 cm Without Extrahepatic Metastases: An Imaging-Based RetrospectiComputed tomography texture analysis to facilitate therapeutic decision making in hepatocellular carcinoma.Triple Arterial Phase MR Imaging with Gadoxetic Acid Using a Combination of Contrast Enhanced Time Robust Angiography, Keyhole, and Viewsharing Techniques and Two-Dimensional Parallel Imaging in Comparison with Conventional Single Arterial Phase.Cirrhotic liver: What's that nodule? The LI-RADS approach.Proposal of a new diagnostic algorithm for hepatocellular carcinoma based on the Japanese guidelines but adapted to the Western world for patients under surveillance for chronic liver disease.Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.Imaging for the Diagnosis of Hepatocellular Carcinoma: a Systematic Review and Meta-analysis.Can combining triple-arterial phase acquisition with fluoroscopic triggering provide both optimal early and late hepatic arterial phase images during gadoxetic acid-enhanced MRI?LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents.Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma.Implementation of LI-RADS into a radiological practice.Magnetic resonance imaging of the cirrhotic liver: diagnosis of hepatocellular carcinoma and evaluation of response to treatment - Part 2.Diagnostic performance of contrast-enhanced multidetector computed tomography and gadoxetic acid disodium-enhanced magnetic resonance imaging in detecting hepatocellular carcinoma: direct comparison and a meta-analysis.Portal vein thrombus and infiltrative HCC: a pictoral review.Magnetic Resonanance Imaging of the Liver (Including Biliary Contrast Agents)-Part 2: Protocols for Liver Magnetic Resonanance Imaging and Characterization of Common Focal Liver LesionsCombined hepatocellular-cholangiocarcinoma: Gadoxetic acid-enhanced MRI findings correlated with pathologic features and prognosis.Magnetic resonance imaging of the cirrhotic liver: diagnosis of hepatocellular carcinoma and evaluation of response to treatment - Part 1.How to Differentiate Borderline Hepatic Nodules in Hepatocarcinogenesis: Emphasis on Imaging Diagnosis.Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.Imaging Techniques for Hepatocellular Carcinoma.Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma.Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.Magnetic Resonance Imaging of Primary Hepatic Malignancies in Patients With and Without Chronic Liver Disease: A Pictorial Review.Contrast-enhanced ultrasound of the liver: technical and lexicon recommendations from the ACR CEUS LI-RADS working group.Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.Patient-specific three-dimensional printing for pre-surgical planning in hepatocellular carcinoma treatment.
P2860
Q26768472-A2429C52-6269-4D01-9B61-96512E101418Q26769602-1389E072-496D-4056-8A41-8DD38B548A79Q26770020-7E3D69EC-FE8C-4C8F-BE9F-7520B8B418DFQ26771246-9EB2410D-011A-40EC-A3A2-1651EE88AA93Q26772319-75D9B9B2-9646-4452-976C-B0FB10952DC5Q27329623-D2D5514E-FB0B-4D22-93A3-AB0C8877A97BQ28075361-F54E821E-C659-4FC9-BE5F-B3F1A83897A6Q30977219-8F60CE1E-7373-46EF-B169-FCF071B85DABQ31079301-C0B6D532-3966-4B29-9B1D-AD02D7CB8AB0Q31154548-9D82BCDD-FFC6-4B4C-9827-CFE2FE273B59Q33561375-0B55A9EB-9759-4CD2-BD37-3BA2BB0E538AQ33617869-DEB7D05B-FB16-41F4-8174-180B4E5A6987Q35619951-E8C93980-DC17-4F2F-9831-2724426FBD57Q36333396-DD5DDF95-86F0-4E38-B435-FDA50D01A254Q36478152-52828D8C-0FBD-4FA7-8A1A-B3C1198C4F3DQ37022447-86B7B642-2B58-4AC3-AE6F-0D7FD9938B9DQ37073543-9FE8A411-9A74-42CF-AB98-E092C7DE581EQ38495409-C2EDCD97-F583-44D4-83C6-C2F6AC4BA8BFQ38574812-E9A04E52-553D-44DF-BE6D-C1A1C1BE363CQ38587512-3BC25C76-2334-45FE-B5BD-DDF265B9A76EQ38599685-2498AB2E-FDD3-4044-BF91-AC7CC1148BFEQ38607851-7D41F295-06E8-4BE2-8F7E-EFA07C8D32C1Q38614744-F24A8EB5-532C-483A-8329-E764B705FB10Q38635644-D6A7AB75-884D-4A42-B891-95B40E8516A8Q38716374-E65634BA-227B-4A63-8B6A-BD4A55E5901DQ38827648-5C6F9E6D-DCE6-4E54-AB2C-5B0DFE7041B1Q38869595-C49BC809-8EA9-4382-8ADD-0E9D8698B30EQ38963115-CCBDF9C8-E267-4C22-BF19-506705779197Q38981474-F6826022-00C4-47B3-89A3-C622F8F88838Q39016627-3BBFA808-9009-4C3A-A951-1915725A5281Q39180805-C8CA74B1-10F3-4DDD-9AA7-8D17167A5609Q39381803-3678A751-D173-4B58-BAE7-6F3859F86F5EQ40517322-F94A528C-9B15-4138-9A26-4C918F8F7D7EQ40563430-0DC04568-C96B-4932-85D6-D484F1B8CDF5Q40989838-2F3A5800-717F-47C7-B3CF-D578BFB7372BQ41962614-ADCA7D92-05BD-4F6A-8DDA-3D0811E8B198Q42278259-E3DF2300-74AA-4BC8-AF89-4EB005D55864Q46088451-E81AA375-3C58-4CA7-B721-26DA1960A8EEQ47145890-638A0DA5-81C8-4060-B71E-5475141E7484Q47234301-92901722-BE45-40CD-AAA8-4CDA6016DE4E
P2860
CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
CT and MR imaging diagnosis an ...... and ancillary imaging features
@ast
CT and MR imaging diagnosis an ...... and ancillary imaging features
@en
CT and MR imaging diagnosis an ...... and ancillary imaging features
@nl
type
label
CT and MR imaging diagnosis an ...... and ancillary imaging features
@ast
CT and MR imaging diagnosis an ...... and ancillary imaging features
@en
CT and MR imaging diagnosis an ...... and ancillary imaging features
@nl
prefLabel
CT and MR imaging diagnosis an ...... and ancillary imaging features
@ast
CT and MR imaging diagnosis an ...... and ancillary imaging features
@en
CT and MR imaging diagnosis an ...... and ancillary imaging features
@nl
P2093
P2860
P50
P356
P1433
P1476
CT and MR imaging diagnosis an ...... and ancillary imaging features
@en
P2093
Claude B Sirlin
Jeong-Min Lee
Jin-Young Choi
P2860
P356
10.1148/RADIOL.14132362
P407
P577
2014-10-01T00:00:00Z